Loading...
•
Dec 31, 2025
AMN Healthcare Q4 2025 Earnings Report
AMN Healthcare reported modest revenue growth in the fourth quarter of 2025 but posted a GAAP net loss, while adjusted EBITDA declined year over year.
Key Takeaways
For Q4 2025, AMN Healthcare generated revenue of 748225000, up 2% year over year. The company reported a GAAP net loss of -7696000, or -0.20 per diluted share, while adjusted diluted EPS was 0.22. Adjusted EBITDA was 54483000 with a margin of 7.3%.
Revenue increased 2% year over year to 748225000.
GAAP net loss was -7696000 compared to a larger loss in the prior year.
Adjusted diluted EPS was 0.22 for the quarter.
Adjusted EBITDA totaled 54483000 with a 7.3% margin.
Revenue by Segment
Forward Guidance
For the first quarter of 2026, AMN expects consolidated revenue between 1225000000 and 1240000000 and adjusted EBITDA margin between 9.7% and 10.2%.
Positive Outlook
- Q1 2026 revenue expected between 1225000000 and 1240000000.
- Adjusted EBITDA margin projected between 9.7% and 10.2%.
- Nurse and Allied revenue expected to increase significantly year over year in Q1.
- Labor disruption revenue estimated at approximately 600000000 in Q1.
- Operating margin guidance between 5.9% and 6.5%.
Challenges Ahead
- Physician and Leadership revenue expected to decline 5-8% year over year in Q1.
- Technology and Workforce revenue projected to decline 16-18% year over year in Q1.
- Gross margin guidance of 23.5% to 24.0% implies compression versus Q4 levels.
- SG&A projected at 14.5% to 15.0% of revenue in Q1.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...